Cargando…
Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria
BACKGROUND: Artemisinin-based combination therapy (ACT) is presently recommended by the World Health Organization as first-line treatment for uncomplicated Plasmodium falciparum malaria in several countries, as a mean of prolonging the effectiveness of first-line malaria treatment regimens. A three-...
Autores principales: | Congpuong, Kanungnit, Bualombai, Pongwit, Banmairuroi, Vick, Na-Bangchang, Kesara |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829592/ https://www.ncbi.nlm.nih.gov/pubmed/20132537 http://dx.doi.org/10.1186/1475-2875-9-43 |
Ejemplares similares
-
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria
por: Saeheng, Teerachat, et al.
Publicado: (2023) -
Population pharmacokinetics of mefloquine given as a 3-day artesunate–mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai–Myanmar border
por: Hoglund, Richard M., et al.
Publicado: (2018) -
Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children
por: Sowunmi, Akintunde, et al.
Publicado: (2009) -
Four years’ monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border
por: Phompradit, Papichaya, et al.
Publicado: (2014) -
Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border
por: Wongsrichanalai, Chansuda, et al.
Publicado: (2008)